These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9844840)

  • 21. Systemic sclerosis and reflux.
    Petronovich JJ; Bock JM
    Ear Nose Throat J; 2013; 92(4-5):192-4. PubMed ID: 23599100
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence-based treatment of frequent heartburn: the benefits and limitations of over-the-counter medications.
    McRorie JW; Gibb RD; Miner PB
    J Am Assoc Nurse Pract; 2014 Jun; 26(6):330-9. PubMed ID: 24825071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroesophageal reflux disease and a HAPPI quality of life.
    Johnston BT
    Am J Gastroenterol; 1999 Jul; 94(7):1723-4. PubMed ID: 10406226
    [No Abstract]   [Full Text] [Related]  

  • 24. Tolerance to H2 receptor antagonist correlates well with the decline in efficacy against gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Furuta K; Adachi K; Komazawa Y; Mihara T; Miki M; Azumi T; Fujisawa T; Katsube T; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1581-5. PubMed ID: 16928220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical therapy of extraesophageal gastroesophageal reflux disease.
    Katz PO
    J Clin Gastroenterol; 2000 Apr; 30(3 Suppl):S42-4. PubMed ID: 10777172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Characteristics of gastroesophageal reflux disease in elderly people].
    Masharova AA; Bordin DS
    Eksp Klin Gastroenterol; 2007; (4):37-40. PubMed ID: 18411443
    [No Abstract]   [Full Text] [Related]  

  • 27. Respiratory complications of gastroesophageal reflux.
    Gonzalez ER; Castell DO
    Am Fam Physician; 1988 Feb; 37(2):169-72. PubMed ID: 2894146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
    Howden CW; Henning JM; Huang B; Lukasik N; Freston JW
    Am J Gastroenterol; 2001 Jun; 96(6):1704-10. PubMed ID: 11419818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On-demand therapy for gastro-oesophageal reflux disease.
    Bytzer P
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S19-22. PubMed ID: 11430504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastroesophageal reflux disease: current treatment approaches.
    Biddle W
    Director; 2003; 11(4):155-9. PubMed ID: 14608699
    [No Abstract]   [Full Text] [Related]  

  • 31. Review article: the management of heartburn in pregnancy.
    Richter JE
    Aliment Pharmacol Ther; 2005 Nov; 22(9):749-57. PubMed ID: 16225482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease.
    Hongo M; Kinoshita Y; Haruma K
    J Gastroenterol; 2008; 43(6):448-56. PubMed ID: 18600389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination therapy.
    Katz P
    Postgrad Med; 2000 May; 107(5 Suppl):31-3; discussion 33-4. PubMed ID: 19667512
    [No Abstract]   [Full Text] [Related]  

  • 34. Heartburn in primary care: problems below the surface.
    Holtmann G; Maldonado-Lopez E; Haag S
    J Gastroenterol; 2004 Nov; 39(11):1027-34. PubMed ID: 15580394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Refractory GERD": acid, nonacid, or not GERD?
    Vaezi MF
    Am J Gastroenterol; 2004 Jun; 99(6):989-90. PubMed ID: 15180714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisapride for nocturnal heartburn.
    Med Lett Drugs Ther; 1994 Feb; 36(915):11-3. PubMed ID: 8283956
    [No Abstract]   [Full Text] [Related]  

  • 37. [H2-blockers in the pediatric practice: is the potential exhausted?].
    Bel'mer SV; Kovalenko AA; Gasilina TV
    Eksp Klin Gastroenterol; 2005; (6):19-22. PubMed ID: 17378381
    [No Abstract]   [Full Text] [Related]  

  • 38. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
    Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. H2-receptor antagonists.
    Nurs Times; 2004 Nov 2-8; 100(44):33. PubMed ID: 15552489
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of heartburn: cost considerations.
    Vakil N
    Postgrad Med; 2000 May; 107(5 Suppl):35-8; discussion 39. PubMed ID: 19667513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.